BioNote, Inc. (KRX:377740)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,925.00
-20.00 (-0.40%)
At close: Mar 27, 2025, 3:30 PM KST

BioNote Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Operating Revenue
102,78090,081479,657622,355631,505
Upgrade
Other Revenue
-0-0-0-
Upgrade
Revenue
102,78090,081479,657622,355631,505
Upgrade
Revenue Growth (YoY)
14.10%-81.22%-22.93%-1.45%1476.89%
Upgrade
Cost of Revenue
51,807101,739139,186110,35251,950
Upgrade
Gross Profit
50,973-11,659340,471512,003579,554
Upgrade
Selling, General & Admin
22,86822,78731,51924,34013,102
Upgrade
Research & Development
13,57713,40516,13811,3007,612
Upgrade
Other Operating Expenses
265.78168.12176.92345.2945.46
Upgrade
Operating Expenses
38,75635,51045,06243,25521,523
Upgrade
Operating Income
12,218-47,168295,410468,748558,031
Upgrade
Interest Expense
-233.55-602.82-84.44-44.25-172.63
Upgrade
Interest & Investment Income
20,05924,6309,715873.6337.56
Upgrade
Earnings From Equity Investments
18,910--147,264--
Upgrade
Currency Exchange Gain (Loss)
40,60310,16424,51224,159-5,726
Upgrade
Other Non Operating Income (Expenses)
1,096420.84-296.63-123.11-75.83
Upgrade
EBT Excluding Unusual Items
92,653-12,556181,992493,612552,094
Upgrade
Gain (Loss) on Sale of Investments
-14,511-88,791219,374376,239143,115
Upgrade
Gain (Loss) on Sale of Assets
20.25265.213,41233.39-11.45
Upgrade
Asset Writedown
-4,835-8,409---
Upgrade
Pretax Income
73,327-109,491414,778869,885695,198
Upgrade
Income Tax Expense
18,065-88,994106,980193,284166,969
Upgrade
Net Income
55,261-20,497307,798676,601528,229
Upgrade
Net Income to Common
55,261-20,497307,798676,601528,229
Upgrade
Net Income Growth
---54.51%28.09%2462.62%
Upgrade
Shares Outstanding (Basic)
102102949494
Upgrade
Shares Outstanding (Diluted)
102102949494
Upgrade
Shares Change (YoY)
-0.01%8.15%0.64%0.14%11.08%
Upgrade
EPS (Basic)
542.00-201.003277.217232.045646.12
Upgrade
EPS (Diluted)
542.00-201.003264.007222.005646.00
Upgrade
EPS Growth
---54.81%27.91%2206.94%
Upgrade
Free Cash Flow
47,454-8,156206,834485,966213,228
Upgrade
Free Cash Flow Per Share
465.43-79.982193.655186.942279.15
Upgrade
Gross Margin
49.59%-12.94%70.98%82.27%91.77%
Upgrade
Operating Margin
11.89%-52.36%61.59%75.32%88.37%
Upgrade
Profit Margin
53.77%-22.75%64.17%108.72%83.65%
Upgrade
Free Cash Flow Margin
46.17%-9.05%43.12%78.09%33.77%
Upgrade
EBITDA
20,404-38,962301,861472,854559,918
Upgrade
EBITDA Margin
19.85%-43.25%62.93%75.98%88.66%
Upgrade
D&A For EBITDA
8,1868,2066,4514,1061,887
Upgrade
EBIT
12,218-47,168295,410468,748558,031
Upgrade
EBIT Margin
11.89%-52.36%61.59%75.32%88.37%
Upgrade
Effective Tax Rate
24.64%-25.79%22.22%24.02%
Upgrade
Advertising Expenses
2,4222,4142,3321,063540.13
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.